DNP (DNP Selectome Fund) YoY EBITDA Growth: 86.96% (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DNP DNP Select Income Fund Inc DNP
54 GF Score
Price $9.96
GF Value $9.58
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is DNP Selectome Fund YoY EBITDA Growth?

DNP Selectome Fund DNP -1.29% 54 YoY EBITDA Growth is 86.96% as of Apr. 2026. GuruFocus rates DNP with a GF Score™ of 54/100 and a GF Value™ of $9.58 (Fairly Valued). The stock has 7 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. DNP Selectome Fund's YoY EBITDA Growth for the quarter that ended in Apr. 2026 was 86.96%.

DNP Selectome Fund's EBITDA per Share for the six months ended in Apr. 2026 was $1.51.

DNP Selectome Fund YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for DNP Selectome Fund's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DNP Selectome Fund YoY EBITDA Growth Chart

DNP Selectome Fund Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 257.65 -98.42 -1,532.00 792.18 -47.30

DNP Selectome Fund Semi-Annual Data
Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24 Oct24 Apr25 Oct25 Apr26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.48 261.48 1.26 -70.36 86.96
DNP
54GF Score
DNP Select Income Fund Inc DNP
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DNP Selectome Fund YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

DNP Selectome Fund's YoY EBITDA Growth for the fiscal year that ended in Oct. 2025 is calculated as:

YoY EBITDA Growth (A: Oct. 2025 )
=(EBITDA per Share (A: Oct. 2025 )-EBITDA per Share (A: Oct. 2024 ))/ | EBITDA per Share (A: Oct. 2024 ) |
=(1.306-2.478)/ | 2.478 |
=-47.30 %

DNP Selectome Fund's YoY EBITDA Growth for the quarter that ended in Apr. 2026 is calculated as:

YoY EBITDA Growth (Q: Apr. 2026 )
=(EBITDA per Share (Q: Apr. 2026 )-EBITDA per Share (Q: Apr. 2025 )) / | EBITDA per Share (Q: Apr. 2025 )) |
=(1.505-0.805)/ | 0.805 |
=86.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 86.96% mean?
DNP Selectome Fund (DNP) has a YoY EBITDA Growth of 86.96% as of Apr. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for DNP Selectome Fund and its competitors.
Is DNP Selectome Fund's YoY EBITDA Growth too high?
DNP Selectome Fund's current YoY EBITDA Growth is 86.96%. Overall, DNP Selectome Fund has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DNP Selectome Fund's YoY EBITDA Growth compare to STEP and CNS?
DNP Selectome Fund's YoY EBITDA Growth of 86.96% can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for an Asset Management company?
A good YoY EBITDA Growth depends on the Asset Management industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for DNP Selectome Fund and its competitors. DNP Selectome Fund's current YoY EBITDA Growth is 86.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DNP Selectome Fund stock overvalued right now?
Based on GuruFocus' analysis, DNP Selectome Fund (DNP) is currently considered Fairly Valued. The stock's GF Value™ is $9.58, compared to a current price of $9.96 — trading 4% above its estimated fair value. The current YoY EBITDA Growth is 86.96%. DNP Selectome Fund's overall GF Score™ is 54/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For DNP Selectome Fund (DNP), the current YoY EBITDA Growth is 86.96% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DNP Selectome Fund (DNP) Overvalued in 2026?

Based on GuruFocus' analysis, DNP Selectome Fund stock appears to be overvalued. The current stock price of $9.96 is trading 4% above its estimated GF Value™ of $9.58. GuruFocus considers DNP Selectome Fund to be Fairly Valued.

Key valuation signals for DNP:

  • YoY EBITDA Growth: 86.96%
  • GF Value™: $9.58 vs. price of $9.96 (4% above fair value)
  • GF Score™: 54/100 with 7 warning signs

No single metric tells the full story. See the DNP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DNP Selectome Fund Business Description

Address 10 South Wacker Drive, Suite 1900, 19th Floor, Chicago, IL, USA, 60606
DNP Select Income Fund Inc is a closed-ended investment management fund. Its investment objectives are current income and long-term growth of income, with capital appreciation as a secondary objective. The Fund seeks to achieve its investment objectives by investing mainly in a diversified portfolio of equity and fixed-income securities of companies in the public utilities industry. Under normal market conditions, more than 65% of the Fund's total assets are invested in securities of public utility companies engaged in the production, transmission, or distribution of electric energy, gas, or telephone services.
54GF Score

Get the complete analysis for DNP

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.96
Price
$9.58
GF Value